Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee considers kratom regulation: age limits, labeling and bans on concentrated synthetics
Summary
Senators heard testimony on SB 6,287, which would restrict kratom products: require labeling and ingredient disclosure, cap alkaloid concentrations, ban sale of products to anyone under 21 and prohibit harmful adulterants; public health witnesses supported stricter controls while industry groups favored a lighter regulatory approach.
Senate Bill 6,287 would regulate kratom products by banning certain concentrated or synthetic derivatives, requiring ingredient and alkaloid‑percentage labeling, setting a 21‑and‑older purchase age, and making violations a gross misdemeanor with a private civil right of action and local authority to adopt stricter ordinances.
Sponsor Sen. Solomon described seeing people develop opioid‑like dependence from concentrated kratom derivatives and said the bill aims…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
